Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity

C H Pegelow1, W Wang, S Granger

  • 1Department of Pediatrics (R-131), University of Miami School of Medicine, PO Box 016960, Miami, FL 33101, USA. cpegelow@miami.edu

Archives of Neurology
|December 26, 2001
PubMed

Insights

Transfusion therapy significantly reduces the risk of silent cerebral infarcts and stroke in children with sickle cell disease and abnormal findings on transcranial Doppler (TCD) and MRI scans. Early detection and treatment are crucial for preventing neurological damage.

Area of Science:

  • Pediatric Neurology
  • Vascular Neurology
  • Medical Imaging

Background:

  • A significant number of children with sickle cell disease (SCD) exhibit silent cerebral infarcts on MRI, despite being neurologically normal.
  • These infarcts represent a risk for future stroke events.

Purpose of the Study:

  • To investigate the impact of transfusion therapy on the development of silent infarcts in children with SCD.
  • To assess the utility of Magnetic Resonance Imaging (MRI) in predicting stroke risk, in conjunction with Transcranial Doppler (TCD) ultrasonography.

Main Methods:

  • Children with elevated TCD velocities were randomized to either long-term transfusion therapy or standard care.
  • Brain MRI was performed at baseline, annually, and upon neurological events.
  • The incidence of new silent lesions or stroke was compared between treatment groups.

Main Results:

  • Among children with silent infarcts at baseline (37%), those receiving standard care had a higher likelihood of developing new lesions or stroke compared to those on transfusion therapy.
  • In the standard care group, pre-existing lesions on MRI significantly increased the risk of subsequent stroke or new silent lesions.

Conclusions:

  • Transfusion therapy effectively reduces the risk of new silent infarcts or stroke in children with SCD who have both abnormal TCD velocities and silent infarcts.
  • Children with both abnormal TCD and silent infarcts who do not receive transfusions face a higher risk of stroke.
  • Screening with TCD and MRI is essential for identifying at-risk children, guiding the consideration of transfusion therapy to prevent neurological complications.
Abstract